Ñî¹óåú´«Ã½Ò•îl

Scientists have shown that a new targeted therapy drug can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening. The finding suggests a possible new treatment option for people with the slow-growing but deadly brain tumor. (University of California - Los Angeles Health Sciences, 6/5)

Health professionals are in urgent need of new antibiotics to tackle resistant bacteria. Researchers have now modified the chemical structure of naturally occurring peptides to develop antimicrobial molecules that bind to novel targets in the bacteria's metabolism. (University of Zurich, 6/1)

The effects of the glycoprotein IIb/IIIa receptor inhibitor tirofiban in patients with acute ischemic stroke but who have no evidence of complete occlusion of large or medium-sized vessels have not been extensively studied. (Wenjie, M.D., et al, 6/1)

Is prophylaxis with letermovir noninferior to valganiclovir for cytomegalovirus (CMV) disease prevention in high-risk CMV-seronegative kidney transplant recipients who receive an organ from a CMV-seropositive donor? (Limaye, MD, Budde, MD and Humar MD, MSc, 6/6)